PTEN and prostate cancer: Quite remarkably, the tumorigenic activity of prostate cancer cells driven by PKCε in conjunction with the PI3K pathway, which is activated upon PTEN loss, largely depends on both canonical and noncanonical NF-κB pathways (127, 129).